Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Biocept announces laboratory testing collaboration with Quest Diagnostics » 08:20
06/22/21
06/22
08:20
06/22/21
08:20
BIOC

Biocept

$4.20 /

-0.13 (-3.00%)

, DGX

Quest Diagnostics

$129.40 /

+1.88 (+1.47%)

Biocept (BIOC) announced…

Biocept (BIOC) announced a collaboration with Quest Diagnostics (DGX) to provide laboratory testing services to Quest patients for its Target Selector NGS-based liquid biopsy targeted lung cancer panel. The Biocept Target Selector NGS-based liquid biopsy assay is a less invasive, lab developed test that can be used for genomic profiling in patients with advanced non-small cell lung cancer, or NSCLC, to help qualify them for advanced targeted therapies and monitor the effectiveness of treatment. With a physician order, patients will be able to provide a blood specimen for testing at one of Quest's 2,200 located patient service centers across the United States. The two parties expect the service to be available to Quest Diagnostics' providers and patients in Q4.

ShowHide Related Items >><<
DGX Quest Diagnostics
$129.40 /

+1.88 (+1.47%)

BIOC Biocept
$4.20 /

-0.13 (-3.00%)

BIOC Biocept
$4.20 /

-0.13 (-3.00%)

08/13/20 Maxim
Biocept price target raised to $2 from $1 at Maxim
DGX Quest Diagnostics
$129.40 /

+1.88 (+1.47%)

05/18/21 Wells Fargo
Amazon could have interest in diagnostics beyond COVID, says Wells Fargo
05/12/21 Mizuho
Quest Diagnostics price target raised to $158 from $149 at Mizuho
05/04/21
Fly Intel: Top five analyst upgrades
05/04/21 UBS
Quest Diagnostics upgraded to Buy from Neutral at UBS
DGX Quest Diagnostics
$129.40 /

+1.88 (+1.47%)

BIOC Biocept
$4.20 /

-0.13 (-3.00%)

DGX Quest Diagnostics
$129.40 /

+1.88 (+1.47%)

BIOC Biocept
$4.20 /

-0.13 (-3.00%)

Over a week ago
Hot Stocks
Biocept received over 420,000 samples for SARS-CoV-2 testing since June 2020 » 08:20
06/15/21
06/15
08:20
06/15/21
08:20
BIOC

Biocept

$4.58 /

-0.07 (-1.51%)

Biocept announced that it…

Biocept announced that it has received more than 420,000 samples for SARS-CoV-2 testing since launching this service in June 2020. The samples are processed using Biocept's RT-PCR-based technology at its CLIA-certified, CAP-accredited, high-complexity molecular laboratory in San Diego.

ShowHide Related Items >><<
BIOC Biocept
$4.58 /

-0.07 (-1.51%)

BIOC Biocept
$4.58 /

-0.07 (-1.51%)

08/13/20 Maxim
Biocept price target raised to $2 from $1 at Maxim
BIOC Biocept
$4.58 /

-0.07 (-1.51%)

BIOC Biocept
$4.58 /

-0.07 (-1.51%)

Hot Stocks
Biocept, and CLEARED4 team to manage testing reporting for Biocept customers » 08:49
06/09/21
06/09
08:49
06/09/21
08:49
BIOC

Biocept

$4.55 /

+0.07 (+1.56%)

Biocept and CLEARED4 have…

Biocept and CLEARED4 have partnered to develop a system for tracking and managing COVID-19 testing requirements and test results for Biocept customers. The new service will leverage CLEARED4's comprehensive health platform, allowing organizations to incorporate customized protocols and requirements for testing students, employees and others. The platform will integrate results from Biocept's RT-PCR-based COVID-19 testing in real-time, and administrators will be able to monitor the program and results for their organizations via a secure dashboard.

ShowHide Related Items >><<
BIOC Biocept
$4.55 /

+0.07 (+1.56%)

BIOC Biocept
$4.55 /

+0.07 (+1.56%)

08/13/20 Maxim
Biocept price target raised to $2 from $1 at Maxim
BIOC Biocept
$4.55 /

+0.07 (+1.56%)

BIOC Biocept
$4.55 /

+0.07 (+1.56%)

Over a month ago
Earnings
Biocept reports Q1 EPS 19c vs. ($1.06) a year ago. » 16:08
05/12/21
05/12
16:08
05/12/21
16:08
BIOC

Biocept

$4.75 /

+0.1 (+2.15%)

Reports Q1 revenue…

Reports Q1 revenue $17.8M, one estimate $13.67M. Biocept reported cash and cash equivalents as of March 31, 2021 of $14.2 million, compared with $14.4M as of December 31, 2020.

ShowHide Related Items >><<
BIOC Biocept
$4.75 /

+0.1 (+2.15%)

BIOC Biocept
$4.75 /

+0.1 (+2.15%)

08/13/20 Maxim
Biocept price target raised to $2 from $1 at Maxim
05/14/20 Brookline
Biocept initiated with a Buy at Brookline
BIOC Biocept
$4.75 /

+0.1 (+2.15%)

BIOC Biocept
$4.75 /

+0.1 (+2.15%)

BIOC Biocept
$4.75 /

+0.1 (+2.15%)

Hot Stocks
Biocept to provide COVID-19 testing to 116 California community colleges » 08:29
04/28/21
04/28
08:29
04/28/21
08:29
BIOC

Biocept

$4.94 /

-0.1 (-1.98%)

Biocept has partnered…

Biocept has partnered with the Foundation for California Community Colleges to make COVID-19 testing available to the 116 California community colleges and their more than 2.1M students. Through the Foundation's CollegeBuys program, Biocept's PCR-based COVID-19 test is now available for community colleges to purchase for students, faculty and staff. Access to and availability of testing will provide information needed to help protect the safety of campus populations and reduce the spread of the virus on campuses and in surrounding communities if/when colleges return from the current remote learning environment as a result of the COVID-19 pandemic.

ShowHide Related Items >><<
BIOC Biocept
$4.94 /

-0.1 (-1.98%)

BIOC Biocept
$4.94 /

-0.1 (-1.98%)

08/13/20 Maxim
Biocept price target raised to $2 from $1 at Maxim
05/14/20 Brookline
Biocept initiated with a Buy at Brookline
BIOC Biocept
$4.94 /

-0.1 (-1.98%)

BIOC Biocept
$4.94 /

-0.1 (-1.98%)

BIOC Biocept
$4.94 /

-0.1 (-1.98%)

Hot Stocks
Biocept announces full commercial launch of CNSide » 08:19
04/21/21
04/21
08:19
04/21/21
08:19
BIOC

Biocept

$4.03 /

-0.14 (-3.36%)

Biocept announced the…

Biocept announced the full commercial launch of CNSide, its cerebrospinal fluid, or CSF, assay designed to better detect and manage treatment of metastatic cancers involving the central nervous system, or CNS. The assay, initially introduced in January 2020, has the ability to offer a timely and accurate method to diagnose disease, identify actionable biomarkers, and assess response to therapy, potentially impacting life expectancy and quality of life.

ShowHide Related Items >><<
BIOC Biocept
$4.03 /

-0.14 (-3.36%)

BIOC Biocept
$4.03 /

-0.14 (-3.36%)

08/13/20 Maxim
Biocept price target raised to $2 from $1 at Maxim
05/14/20 Brookline
Biocept initiated with a Buy at Brookline
BIOC Biocept
$4.03 /

-0.14 (-3.36%)

BIOC Biocept
$4.03 /

-0.14 (-3.36%)

BIOC Biocept
$4.03 /

-0.14 (-3.36%)

Hot Stocks
Biocept has received over 350,000 samples for SARS-CoV-2 testing services » 08:09
04/14/21
04/14
08:09
04/14/21
08:09
BIOC

Biocept

$4.41 /

+0.11 (+2.56%)

Biocept announced that…

Biocept announced that since the company began offering SARS-CoV-2 testing services in June 2020, it has now received more than 350,000 samples for testing. These samples are processed using Biocept's RT-PCR technology at its CLIA-certified, CAP-accredited high-complexity molecular laboratory in San Diego. "We are exceptionally proud to continue supporting our community with SARS-CoV-2 testing and providing healthcare providers with rapid turnaround of valuable information to help contain viral spread," said Michael Nall, President and CEO of Biocept. "RT-PCR testing for COVID-19 currently remains an important component of our business while we focus on our core business, including the opportunity to serve patients diagnosed with advanced cancer through commercializing our differentiated CNSide(TM) neuro-oncology offerings."

ShowHide Related Items >><<
BIOC Biocept
$4.41 /

+0.11 (+2.56%)

BIOC Biocept
$4.41 /

+0.11 (+2.56%)

08/13/20 Maxim
Biocept price target raised to $2 from $1 at Maxim
05/14/20 Brookline
Biocept initiated with a Buy at Brookline
BIOC Biocept
$4.41 /

+0.11 (+2.56%)

BIOC Biocept
$4.41 /

+0.11 (+2.56%)

BIOC Biocept
$4.41 /

+0.11 (+2.56%)

Conference/Events
Biocept to hold a conference call » 11:55
04/08/21
04/08
11:55
04/08/21
11:55
BIOC

Biocept

$4.71 /

+0.18 (+3.97%)

Management holds a KOL…

Management holds a KOL Neuro12-Oncology conference call on April 8 at 12 pm. Webcast Link

ShowHide Related Items >><<
BIOC Biocept
$4.71 /

+0.18 (+3.97%)

BIOC Biocept
$4.71 /

+0.18 (+3.97%)

08/13/20 Maxim
Biocept price target raised to $2 from $1 at Maxim
05/14/20 Brookline
Biocept initiated with a Buy at Brookline
BIOC Biocept
$4.71 /

+0.18 (+3.97%)

  • 14
    Apr
BIOC Biocept
$4.71 /

+0.18 (+3.97%)

BIOC Biocept
$4.71 /

+0.18 (+3.97%)

Conference/Events
Biocept to hold a conference call » 04:55
04/08/21
04/08
04:55
04/08/21
04:55
BIOC

Biocept

$4.53 /

-0.24 (-5.03%)

Management holds a KOL…

Management holds a KOL Neuro12-Oncology conference call on April 8 at 12 pm. Webcast Link

ShowHide Related Items >><<
BIOC Biocept
$4.53 /

-0.24 (-5.03%)

BIOC Biocept
$4.53 /

-0.24 (-5.03%)

08/13/20 Maxim
Biocept price target raised to $2 from $1 at Maxim
05/14/20 Brookline
Biocept initiated with a Buy at Brookline
BIOC Biocept
$4.53 /

-0.24 (-5.03%)

  • 14
    Apr
BIOC Biocept
$4.53 /

-0.24 (-5.03%)

BIOC Biocept
$4.53 /

-0.24 (-5.03%)

Conference/Events
Biocept to hold a conference call » 15:16
04/05/21
04/05
15:16
04/05/21
15:16
BIOC

Biocept

$4.87 /

+ (+0.00%)

Management holds a KOL…

Management holds a KOL Neuro12-Oncology conference call on April 8 at 12 pm. Webcast Link

ShowHide Related Items >><<
BIOC Biocept
$4.87 /

+ (+0.00%)

BIOC Biocept
$4.87 /

+ (+0.00%)

08/13/20 Maxim
Biocept price target raised to $2 from $1 at Maxim
05/14/20 Brookline
Biocept initiated with a Buy at Brookline
BIOC Biocept
$4.87 /

+ (+0.00%)

  • 14
    Apr
BIOC Biocept
$4.87 /

+ (+0.00%)

BIOC Biocept
$4.87 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.